Syba Sunny
Syba Sunny
Navigating the benefits and harms of GLP-1 and GLP-1/GIP agonists in obesity [0.03%]
GLP-1和GLP-1/GIP激动剂治疗肥胖的利弊及其应对策略
Raymond OConnor
Raymond OConnor
Obesity is becoming increasingly common worldwide. Glucagon-like peptide-1 receptor agonist (GLP-1 RA) type drugs have the potential to help patients achieve considerable weight loss. Several benefits have been described in the short term, ...
Syba Sunny
Syba Sunny
Julian Treadwell
Julian Treadwell
Jasmin Mahajne,Ernestina Angarola,Emanuel Della Torre et al.
Jasmin Mahajne et al.
Tarini Prasad Dandasena,Vaibhav Ingle,M Sukumar et al.
Tarini Prasad Dandasena et al.